| Joseph Schuller, MD | |
|
401 Castle Creek Rd, Aspen, CO 81611-1159 | |
| (970) 544-7385 | |
| Not Available |
| Full Name | Joseph Schuller |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 20 Years |
| Location | 401 Castle Creek Rd, Aspen, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144367434 | NPI | - | NPPES |
| 49526847 | Medicaid | CO |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aspen Valley Hospital | Aspen, CO | Hospital |
| Valley View Hospital Association | Glenwood springs, CO | Hospital |
| Grand River Hospital District | Rifle, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspen Valley Hospital Clinics, Pllc | 3375891013 | 14 |
| Aspen Valley Hospital District | 9234123266 | 11 |
News Archive
Wellness Center USA, Inc., a Schaumburg IL based healthcare and nutraceutical company, reported the closing of its Psoria-Shield Inc. (PSI) acquisition. PSI is a Tampa, FL based developer and manufacturer of UltraViolet (UV) phototherapy devices for the treatment of skin diseases.
The Arizona Board of Regents presented the Translational Genomics Research Institute with its 2015 Regents' Award for Outstanding Service to Higher Education, recognizing the extensive research TGen has conducted in association with Northern Arizona University.
Implementation Choices for the Children's Health Insurance Program Reauthorization Act of 2009 - This report examines two key areas of the implementation process of the Children's Health Insurance Program Reauthorization Act (CHIPRA) of 2009 - outreach and enrollment, and quality of care - and issues a set of recommendations. "Recommendations include: giving funding priority to states that will adopt or maintain key simplifications… ensuring quality measures focus on priority health needs for children, and building quality measurement and improvement capabilities into electronic health information systems, among others," according to a Commonwealth Fund description of the report (Simpson, Fairbrother, Touschner and Guyer, 9/10).
YM BioSciences Inc., announced that it has received ethics board approval to expand enrolment in its Phase I/II clinical trial of CYT387 at Mayo Clinic in patients with myelofibrosis, a chronic debilitating condition, where patient's bone marrow is replaced by scar tissue.
Patients with advanced-stage cancer experience very poor sleep quality and often have troubling staying awake, says Emory University researcher Kathy Parker, PhD, RN.
› Verified 6 days ago
| Entity Name | Aspen Valley Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518960814 PECOS PAC ID: 9234123266 Enrollment ID: O20040413000642 |
News Archive
Wellness Center USA, Inc., a Schaumburg IL based healthcare and nutraceutical company, reported the closing of its Psoria-Shield Inc. (PSI) acquisition. PSI is a Tampa, FL based developer and manufacturer of UltraViolet (UV) phototherapy devices for the treatment of skin diseases.
The Arizona Board of Regents presented the Translational Genomics Research Institute with its 2015 Regents' Award for Outstanding Service to Higher Education, recognizing the extensive research TGen has conducted in association with Northern Arizona University.
Implementation Choices for the Children's Health Insurance Program Reauthorization Act of 2009 - This report examines two key areas of the implementation process of the Children's Health Insurance Program Reauthorization Act (CHIPRA) of 2009 - outreach and enrollment, and quality of care - and issues a set of recommendations. "Recommendations include: giving funding priority to states that will adopt or maintain key simplifications… ensuring quality measures focus on priority health needs for children, and building quality measurement and improvement capabilities into electronic health information systems, among others," according to a Commonwealth Fund description of the report (Simpson, Fairbrother, Touschner and Guyer, 9/10).
YM BioSciences Inc., announced that it has received ethics board approval to expand enrolment in its Phase I/II clinical trial of CYT387 at Mayo Clinic in patients with myelofibrosis, a chronic debilitating condition, where patient's bone marrow is replaced by scar tissue.
Patients with advanced-stage cancer experience very poor sleep quality and often have troubling staying awake, says Emory University researcher Kathy Parker, PhD, RN.
› Verified 6 days ago
| Entity Name | Valley View Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1437271285 PECOS PAC ID: 1850294778 Enrollment ID: O20060127000173 |
News Archive
Wellness Center USA, Inc., a Schaumburg IL based healthcare and nutraceutical company, reported the closing of its Psoria-Shield Inc. (PSI) acquisition. PSI is a Tampa, FL based developer and manufacturer of UltraViolet (UV) phototherapy devices for the treatment of skin diseases.
The Arizona Board of Regents presented the Translational Genomics Research Institute with its 2015 Regents' Award for Outstanding Service to Higher Education, recognizing the extensive research TGen has conducted in association with Northern Arizona University.
Implementation Choices for the Children's Health Insurance Program Reauthorization Act of 2009 - This report examines two key areas of the implementation process of the Children's Health Insurance Program Reauthorization Act (CHIPRA) of 2009 - outreach and enrollment, and quality of care - and issues a set of recommendations. "Recommendations include: giving funding priority to states that will adopt or maintain key simplifications… ensuring quality measures focus on priority health needs for children, and building quality measurement and improvement capabilities into electronic health information systems, among others," according to a Commonwealth Fund description of the report (Simpson, Fairbrother, Touschner and Guyer, 9/10).
YM BioSciences Inc., announced that it has received ethics board approval to expand enrolment in its Phase I/II clinical trial of CYT387 at Mayo Clinic in patients with myelofibrosis, a chronic debilitating condition, where patient's bone marrow is replaced by scar tissue.
Patients with advanced-stage cancer experience very poor sleep quality and often have troubling staying awake, says Emory University researcher Kathy Parker, PhD, RN.
› Verified 6 days ago
| Entity Name | Aspen Valley Hospital Clinics, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003306168 PECOS PAC ID: 3375891013 Enrollment ID: O20180813000798 |
News Archive
Wellness Center USA, Inc., a Schaumburg IL based healthcare and nutraceutical company, reported the closing of its Psoria-Shield Inc. (PSI) acquisition. PSI is a Tampa, FL based developer and manufacturer of UltraViolet (UV) phototherapy devices for the treatment of skin diseases.
The Arizona Board of Regents presented the Translational Genomics Research Institute with its 2015 Regents' Award for Outstanding Service to Higher Education, recognizing the extensive research TGen has conducted in association with Northern Arizona University.
Implementation Choices for the Children's Health Insurance Program Reauthorization Act of 2009 - This report examines two key areas of the implementation process of the Children's Health Insurance Program Reauthorization Act (CHIPRA) of 2009 - outreach and enrollment, and quality of care - and issues a set of recommendations. "Recommendations include: giving funding priority to states that will adopt or maintain key simplifications… ensuring quality measures focus on priority health needs for children, and building quality measurement and improvement capabilities into electronic health information systems, among others," according to a Commonwealth Fund description of the report (Simpson, Fairbrother, Touschner and Guyer, 9/10).
YM BioSciences Inc., announced that it has received ethics board approval to expand enrolment in its Phase I/II clinical trial of CYT387 at Mayo Clinic in patients with myelofibrosis, a chronic debilitating condition, where patient's bone marrow is replaced by scar tissue.
Patients with advanced-stage cancer experience very poor sleep quality and often have troubling staying awake, says Emory University researcher Kathy Parker, PhD, RN.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Schuller, MD 401 Castle Creek Rd, Aspen, CO 81611-1159 Ph: (970) 544-7385 | Joseph Schuller, MD 401 Castle Creek Rd, Aspen, CO 81611-1159 Ph: (970) 544-7385 |
News Archive
Wellness Center USA, Inc., a Schaumburg IL based healthcare and nutraceutical company, reported the closing of its Psoria-Shield Inc. (PSI) acquisition. PSI is a Tampa, FL based developer and manufacturer of UltraViolet (UV) phototherapy devices for the treatment of skin diseases.
The Arizona Board of Regents presented the Translational Genomics Research Institute with its 2015 Regents' Award for Outstanding Service to Higher Education, recognizing the extensive research TGen has conducted in association with Northern Arizona University.
Implementation Choices for the Children's Health Insurance Program Reauthorization Act of 2009 - This report examines two key areas of the implementation process of the Children's Health Insurance Program Reauthorization Act (CHIPRA) of 2009 - outreach and enrollment, and quality of care - and issues a set of recommendations. "Recommendations include: giving funding priority to states that will adopt or maintain key simplifications… ensuring quality measures focus on priority health needs for children, and building quality measurement and improvement capabilities into electronic health information systems, among others," according to a Commonwealth Fund description of the report (Simpson, Fairbrother, Touschner and Guyer, 9/10).
YM BioSciences Inc., announced that it has received ethics board approval to expand enrolment in its Phase I/II clinical trial of CYT387 at Mayo Clinic in patients with myelofibrosis, a chronic debilitating condition, where patient's bone marrow is replaced by scar tissue.
Patients with advanced-stage cancer experience very poor sleep quality and often have troubling staying awake, says Emory University researcher Kathy Parker, PhD, RN.
› Verified 6 days ago
Carl Schiller, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 E Main St, Ste 201, Aspen, CO 81611 Phone: 970-544-1131 | |
Susan Zimet, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 E Main St Ste 103, Aspen, CO 81611 Phone: 970-544-1131 Fax: 844-384-5032 | |
Caroline Taylor Mears, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 401 Castle Creek Rd, Aspen, CO 81611 Phone: 970-279-4111 | |
Dr. Timothy C Rodell, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 201 Midland Ave, Aspen, CO 81611 Phone: 970-948-5844 Fax: 970-948-5844 | |
Eugene Howard Seymour, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 390 N Spring St, Aspen, CO 81611 Phone: 310-486-5677 Fax: 630-604-6402 | |
Barry Mink, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 E Main St, Ste 201, Aspen, CO 81611 Phone: 970-544-1131 |